Aza compound or pharmaceutically acceptable salt thereof as well as preparation method and application of aza compound or pharmaceutically acceptable salt

The invention discloses an aza compound or a pharmaceutically acceptable salt thereof as well as a preparation method and application thereof. The structural formula of the aza compound is shown as a formula (2), wherein X is a carbon atom or a nitrogen atom; n is selected from 1, 2 or 3; r1 is one...

Full description

Saved in:
Bibliographic Details
Main Authors LIU ZIRUI, WANG YONGDONG, HUANG ZHIPENG, SHI QIU, ZHU SHIFA
Format Patent
LanguageChinese
English
Published 17.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention discloses an aza compound or a pharmaceutically acceptable salt thereof as well as a preparation method and application thereof. The structural formula of the aza compound is shown as a formula (2), wherein X is a carbon atom or a nitrogen atom; n is selected from 1, 2 or 3; r1 is one or more groups on a ring A, and R1 is independently selected from hydrogen, halogen, C1-C6 alkyl groups, C1-C6 alkoxy groups, trifluoromethyl, C1-C6 ester groups, C1-C6 alkylamino groups, cyano groups or phenyl groups; when the number of the R1 is more than one, the two R1 can be connected through a saturated or unsaturated C1-C4 carbon chain; r < 2 > is selected from hydrogen, carbobenzoxy, t-butyloxycarbonyl, fluorenylmethoxycarbonyl, phthaloyl, p-toluenesulfonyl, trifluoroacetyl, p-methoxybenzyl, benzyl or methylsulfonyl; and R3 is selected from hydrogen, phenyl or C1-C6 alkyl. The aza compound or the pharmaceutically acceptable salt of the aza compound has the activity of inhibiting COX-2. 本发明公开了一种氮杂类化合物或其药学上可接
AbstractList The invention discloses an aza compound or a pharmaceutically acceptable salt thereof as well as a preparation method and application thereof. The structural formula of the aza compound is shown as a formula (2), wherein X is a carbon atom or a nitrogen atom; n is selected from 1, 2 or 3; r1 is one or more groups on a ring A, and R1 is independently selected from hydrogen, halogen, C1-C6 alkyl groups, C1-C6 alkoxy groups, trifluoromethyl, C1-C6 ester groups, C1-C6 alkylamino groups, cyano groups or phenyl groups; when the number of the R1 is more than one, the two R1 can be connected through a saturated or unsaturated C1-C4 carbon chain; r < 2 > is selected from hydrogen, carbobenzoxy, t-butyloxycarbonyl, fluorenylmethoxycarbonyl, phthaloyl, p-toluenesulfonyl, trifluoroacetyl, p-methoxybenzyl, benzyl or methylsulfonyl; and R3 is selected from hydrogen, phenyl or C1-C6 alkyl. The aza compound or the pharmaceutically acceptable salt of the aza compound has the activity of inhibiting COX-2. 本发明公开了一种氮杂类化合物或其药学上可接
Author WANG YONGDONG
ZHU SHIFA
LIU ZIRUI
SHI QIU
HUANG ZHIPENG
Author_xml – fullname: LIU ZIRUI
– fullname: WANG YONGDONG
– fullname: HUANG ZHIPENG
– fullname: SHI QIU
– fullname: ZHU SHIFA
BookMark eNqVjUsKwkAQRGehC393aA8gOIgBlyEorly5D-2kQwKd6WZmguhRPK2JeABdFRT1Xs3NxIunmXnlTwQnnUrvK5AA2mDo0FGfWofMD0DnSBPemCAiJ0gNBZIaMMKdmMfUQIoBUyseOkqNVICDDVV5kHzqEfjzaWmmNXKk1TcXZn06XovzhlRKijqgnlJZXKzdZ9Yetjbf_bJ5Ax5aVWA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 一种氮杂䓬类化合物或其药学上可接受的盐及其制备方法和应用
ExternalDocumentID CN115611901A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN115611901A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN115611901A3
Notes Application Number: CN202110809157
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230117&DB=EPODOC&CC=CN&NR=115611901A
ParticipantIDs epo_espacenet_CN115611901A
PublicationCentury 2000
PublicationDate 20230117
PublicationDateYYYYMMDD 2023-01-17
PublicationDate_xml – month: 01
  year: 2023
  text: 20230117
  day: 17
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies SOUTH CHINA UNIVERSITY OF TECHNOLOGY
GENLFARM (GUANGZHOU) TECHNOLOGY INC
XINYUAN (GUANGZHOU) PHARMACEUTICAL RESEARCH CO., LTD
RelatedCompanies_xml – name: GENLFARM (GUANGZHOU) TECHNOLOGY INC
– name: SOUTH CHINA UNIVERSITY OF TECHNOLOGY
– name: XINYUAN (GUANGZHOU) PHARMACEUTICAL RESEARCH CO., LTD
Score 3.5783348
Snippet The invention discloses an aza compound or a pharmaceutically acceptable salt thereof as well as a preparation method and application thereof. The structural...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Aza compound or pharmaceutically acceptable salt thereof as well as preparation method and application of aza compound or pharmaceutically acceptable salt
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230117&DB=EPODOC&locale=&CC=CN&NR=115611901A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fS8MwED_mFPVNp6LzDxGkb8W1W9v0ociWdgxh3ZApextpmzFltGWtiPsoflpz3eb6ouBTQkIuNMnlrpe73wHcRY0pp0ZAVa5zqrYCI5Q1GqiRQTmPpH4vbIxG7vtm77n1ODbGFXjbxMIUOKEfBTii5KhQ8nte3Nfp1ojlFr6V2X3wKpuSh-7IcZX137GOx9VS3I7jDQfugCmMOcxX_CdHKj6mhsKvvQO7qEYjzr730sGolLQsUrpHsDeU1OL8GCrLWQ0O2CbzWg32--sHb1ld8152Al_tJSfoAY6JkEiyIOmsbI6efxIeoo8KxkKRjM9zgrqdSKaEZwRNdFimC7EC-05iskoeTbikVnrGJjjgnzOdwm3XG7GeKj9y8rOiE-Zv16N5BtU4icU5kMAWpohsRBXUW0I0bGoLbgqNhvJeCA3rAuq_06n_1XkJh7g7aLvQrCuo5ot3cS2leR7cFNvwDa2IqQY
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3bTsIw9ATRiG-KGsVbTczeFmGwrXtYDHQQVBjEoOGNdFsJGrItbMbIp_i19gwQXjTxqU2bnqaX03PpuQDcBOUxp7pHVa5xqtY83Zc16qmBTjkPJH8vLPRG7rpG-7n2MNSHOXhb-cJkcUI_suCIEqN8ie9p9l7HayWWk9lWJrfeq2yK7loD21GW0rGG19VUnIbd7PecHlMYs5mruE-2ZHyMChK_-hZsm1IkzESllwZ6pcSbJKW1Dzt9CS1MDyA3nxShwFaZ14qw211-eMvqEveSQ_iqzzlBC3BMhESiGYknm-ro6SfhPtqooC8USfg0JcjbiWhMeEJQRYdlPBOLYN9RSBbJowmX0Da-sQkO-OdMR3Ddag5YW5WLHP3s6Ii56_2oHkM-jEJxAsSzhCECC6MKajUhyha1BDdEhfryXfB18xRKv8Mp_dV5BYX2oNsZde7dxzPYw5NCPUbFPId8OnsXF5Kyp95ldiTfuySr8A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Aza+compound+or+pharmaceutically+acceptable+salt+thereof+as+well+as+preparation+method+and+application+of+aza+compound+or+pharmaceutically+acceptable+salt&rft.inventor=LIU+ZIRUI&rft.inventor=WANG+YONGDONG&rft.inventor=HUANG+ZHIPENG&rft.inventor=SHI+QIU&rft.inventor=ZHU+SHIFA&rft.date=2023-01-17&rft.externalDBID=A&rft.externalDocID=CN115611901A